期刊文献+

免疫抑制性细胞在免疫性血小板减少症中的作用 被引量:1

The Role of Immunosuppressive Cells in Immune Thrombocytopenia
下载PDF
导出
摘要 免疫性血小板减少症(ITP)是一种自身免疫性疾病,其特征是循环血小板数量显著减少及常伴有出血。虽然ITP的发病机制尚未完全阐明,但目前普遍认为T、B淋巴细胞功能紊乱参与了ITP的发病机制。ITP临床表现复杂,治疗过程存在异质性,其原因在于病理机制的复杂性。因此,更好地了解ITP的不同发病机制对于探索更有效的治疗是必要的。最近,越来越多的研究揭示免疫抑制性细胞对ITP的发病机制存在重要影响。为此,本文主要综述不同免疫抑制细胞在ITP中的作用,以期为临床探索该病的治疗方法提供帮助。 Immune thrombocytopenia(ITP)is an autoimmune disease characterized by a significant reduction in the number of circulating platelets and often accompanied by bleeding.Although the pathogenesis of ITP has not been fully elucidated,it is generally believed that the dysfunction of T and B lymphocytes is involved in the pathogenesis of ITP.The clinical manifestations of ITP are complex and the treatment process is heterogeneous.The reason lies in the complexity of the pathological mechanism.Therefore,a better understanding of the different pathogenesis of ITP is necessary to explore more effective treatments.Recently,more and more studies have revealed that immunosuppressive cells have an important influence on the pathogenesis of ITP.To this end,this article mainly reviews the role of different immunosuppressive cells in ITP,in order to provide help for clinical exploration of the treatment of the disease.
作者 陆皓 陈海琳 鲍计章 周永明 LU Hao;CHEN Hai-lin;BAO Ji-zhang;ZHOU Yong-ming(Department of Hematology,Yueyang Hospital of Integrated Traditional Chinese and Western Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 200437,China)
出处 《医学信息》 2021年第13期23-27,32,共6页 Journal of Medical Information
基金 国家自然科学基金项目(编号:81774258) 上海市名老中医学术经验研究工作室项目(编号:SHGZS-2017019)。
关键词 免疫性血小板减少症 免疫抑制性细胞 淋巴细胞 循环血小板 Immune thrombocytopenia Immunosuppressive cells Lymphocytes Circulating platelets
  • 相关文献

参考文献18

二级参考文献147

  • 1王军,胡玉莲,王西阁,冯建飞,汤有才.特发性血小板减少性紫癜患儿sCD40配体及其mRNA表达水平的变化[J].中华血液学杂志,2006,27(5):348-349. 被引量:4
  • 2虞积仁.特发性血小板减少性紫癜[A].见:张之南,沈悌主编.血液病诊断及疗效标准[M].第3版.北京:科学技术版社,2007.172-176.
  • 3Zhu B, Bando Y, Xiao S, et al. CDllb^+Ly-6C(hi) suppressive monocytes in experimental autoimmune encephalomyelitis. J Im- munol, 2007, 179(8) : 5228-5237.
  • 4Kerr EC, Raveney B J, Copland DA, et al. Analysis of retinal cel- lular infiltrate in experimental autoimmune uveoretinitis reveals multiple regulatory cell populations. J Autoimmun, 2008, 31 (4) : 354-361.
  • 5Haile LA, yon Wasielewski R, Gamrekelashvili J, et al. Myeloid- derived suppressor cells in inflammatory bowel disease: a new im- munoregulatory pathway. Gastroenterology, 2008, 135 ( 3 ) : 871- 881, 881. el-5.
  • 6Highfi11 SL, Rodriguez PC, Zhou Q, et al. Bone marrow myeloid- derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regu- lated by interleukin-13. Blood, 2010, 116 (25) : 5738-5747.
  • 7Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol, 2009, 9(3) : 162-174.
  • 8Zhang W, Liang S, Wu J, et al. Human inhibitory receptor immu- noglobulin-like transcript 2 amplifies CD1 lb^+Grl^+ myeloid-derived suppressor cells that promote long-term survival of allografts. Transplantation, 2008, 86(8) : 1125-1134.
  • 9Yang R, Cai Z, Zhang Y, et al. CD80 in immune suppression by mouse ovarian carcinoma-associated Gr-1^+CDllb^+ myeloid cells. Cancer Res, 2006, 66(13): 6807-6815.
  • 10Youn JI, Nagaraj S, Collazo M, et al. Subsets of myeloid-derived suppressor ceils in tumor-bearing mice. J Immunol, 2008, 181 ( 8 ) : 5791-5802.

共引文献388

同被引文献8

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部